Delivery Order SPE2DB22D2007-SPE2DB24FJ6JR

Award Date 9/24/24
Potential Completion Date 9/25/24
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $14,247.44, is for the supply of 4565634369 - STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. The award is a firm fixed-price delivery order with an ultimate completion date of August 30, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $14,309.70 firm fixed-price contract is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical drug. The contract has an ultimate completion date of August 26, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the United States, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $21,371.16 firm-fixed-price contract is for the supply of 4,565,371,847 units of the specialty medication STELARA (45 mg/0.5 mL syringe). The award has an ultimate completion date of August 8, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued at up to...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,059.52 firm-fixed-price contract is for the delivery of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of June 27, 2025 and is not set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $7,154.84 firm-fixed-price contract is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract has an ultimate completion date of August 15, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of essential medical commodities to...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $18,102.04 firm fixed-price contract is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract is not set aside and has an ultimate completion date of July 29, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by the DLA and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $4,366.28 firm-fixed-price delivery order is for the supply of STELARA 45 MG/0.5 ML syringes, a specialty pharmaceutical product. The contract has a completion date of July 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA and other agencies, valued up to $999,999,999, to provide...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of STELARA 90 MG/ML syringes, a specialty pharmaceutical product, with a ceiling value of $13,725.85 and a completion date of September 18, 2024. The contract is a Firm Fixed Price type with no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $44,321.80 fixed-price contract is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of September 5, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $16,930.20, is for the supply of STELARA 90 MG/ML syringes. It is a firm fixed-price contract with an ultimate completion date of August 23, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC covers...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ6JR
    Delivery Order

This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the delivery of 4565924194 units of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract has a firm fixed price of $14,682.03 and an ultimate completion date of September 25, 2024. There is no set-aside designation for this award. AmerisourceBergen, one of the largest pharmaceutical distributors in the United States, has been awarded multiple indefinite delivery contracts (IDCs) by the DLA and other federal agencies to supply a wide range of pharmaceutical and medical products to support military treatment facilities, veterans' healthcare, and other government healthcare programs.

Generated 12/24/24, 9:12 AM